Prader-Willi syndrome is an uncommon multisystem genetic disorder caused by defects of chromosome 15 (15q11-q13)
Obesidad mórbida en una adolescente con síndrome de Prader-Willi 1 , and is a neurodevelopmental condition associated with early onset of childhood obesity 2 . The prevalence of PWS is 1:15,000-25,000 3 , and the associated genetic changes involve deletions of the paternally derived chromosome 15, maternal disomy of chromosome 15, imprinting center mutations, and translocations [4] [5] [6] [7] [8] . The PWS clinical spectrum includes: decreased fetal movement; neonatal hypotonia; infantile feeding problems and failure to thrive; childhood-onset hyperphagia; morbid obesity; facial dysmorphic features; mental retardation; reduced growth-hormone (GH) secretion; hypogonadism; short stature for family; small and narrow hands and feet for height and age; low lean body mass; behavioral abnormalities; sleep disturbances; and self-injury tendency 2, 3, [5] [6] [7] . PWS has been considered an uncommon condition, and may be underdiagnosed because the features that raise diagnostic suspicion evolve over time or may be nonspecific; therefore, the clinical criteria must be assessed in accordance to the patient's age range 7 . The suspected cases can be confirmed by molecular resources including methylation, cytogenetic, or fluorescence in situ hybridization tests [6] [7] [8] .
Hormone treatment for GH deficiency and hypogonadism will benefit patients with PWS 5,9 , resulting in cognitive, emotional and social positive effects 10 .
However, more severe obsessive-compulsive and selfinjury problems call for a special psychiatric attention and treatment 11 . Selective serotonin reuptake inhibitors (SSRIs) as fluoxetine have been effective to treat compulsivity and maladaptative behaviors 12 . Because of increased morbidity and premature mortality, often associated with hyperlipidemia and coronary disease, preventive measures in addition to clinical and surgical control of morbid obesity have been a major objective in the treatment of cases with PWS 9,13,14 .
CASE REPORT
A 17-year-old woman with diagnosis of Prader-Willi syndrome during early infancy was admitted with BMI of 74 Kg/m 2 , 147 cm in height, in anasarca and with marked cyanosis, dyspnea and oliguria. She presented left flank and lumbar colic pain. She was in use of fluoxetine for six months, and evolved with severe high blood pressure and respiratory failure, that needed intensive care support. Huge edema and conspicuous self-injury signs were seen on her trunk, forearms, hands and fingers (Figures 1 and 2) . Menarche occurred by 14 years, when she weighed 89. Urinalysis detected urate crystals, and urine culture was negative. Further data were: cortisol level 9.20 µg/dL (normal range 6.2 to 19 µg/dL); normal TSH (2.9 µUI/mL) and free-T4 (0.97 ng/dL); serum complement 188 U/CAE (normal ≥ 60 U/CAE) and normal C3 and C4; anti-DNA antibody 34.1 UI/mL (normal ≤ 35 UI/mL); normal ASLO 72.1 UI/mL; rheumatoid factor 9.56 U/mL (normal ≤ 15 U/mL); and negative tests for HIV and C and B hepatitis viruses.
In addition to fluoxetine, her initial treatment included diuretic, antihypertensive and allopurinol, and oxygen by catheter or mask. During the first two weeks of admission, she had respiratory function deterioration, with sleep apnea episodes, that improved with intensive care support ( Table 1 ) and loss of 30 Kg in her body weight. Another occurrence was erysipelas in her legs ( Figure 2C ), successfully treated with penicillin. After 50 days of admission, she was discharged to home care assistance.
DISCUSSION
This Brazilian adolescent presented typical PWS dysmorphic features, hyperphagia, morbid obesity, mental retardation, self-injury, sleep apnea, nephrolithiasis, and anasarca. The initial concern was about the origin of edema associated with morbid obesity, which included a differential diagnoses with Cushing syndrome, hypothyroidism, nephrotic and nephritic syndromes. The normal cortisol, as well as normal TSH and free-T4 levels discarded the hypotheses of Cushing syndrome and hypothyroidism. Furthermore, the normal serum complement and C3 and C4 fractions, normal anti-DNA antibody, ASLO and rheumatoid factor, in addition to negative tests for HIV and C and B hepatitis viruses, and unremarkable urinalysis practically ruled out glomerulonephritis and nephrotic syndrome. Other causes of edema could be heart or hepatic failure; nevertheless, there were no physical or complementary data to support these possibilities. Additional hypotheses included adverse effects of fluoxetine, as the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) 15 and/or paradoxal weight gain 16 . Although a rapid loss of weight was observed following the fluoxetine interruption, the patient did not show hyponatremia or hypokalemia. The low caloric diet also played an important role in her clinical improvement, with gradual lessening of symptoms related to pulmonary hypoventilation (snoring, exercise dyspnea, cyanosis and sleep apnea) 17, 18 . The benefical effects of weight loss and Figure 2A . Small and narrow hand for age, reduction of obesity and absence of edema. Figure 2B . Self-injury change in the fourth left finger. Figure 2C . Feature of the right inferior limb erysipela, near to hospital discharge.
C A S O C L Í N I C O
of the non invasive mechanical ventilation on the respiratory parameters are shown in Table 2 . Worth of note is also the finding of erysipelas in the legs of a patient with morbid obesity, which is very often associated with drainage impairment both through the venous and the lymph vessels from the legs.
The patient also presented a colicky pain due to a kidney stone of uric acid. Although nephrolithiasis has been rarely reported in PWS, the hyperuricemia and urine uric acid crystals could be associated with overeating and purine overproduction 19 . Interestingly, the Lesch-Nyhan syndrome shares with PWS the following features: cognitive deficit, attention and psychomotor delay and self-injury behavior, in addition to hyperuricemia, urate cristaluria and nephrolithiasis. Notwithstanding, Lesch-Nyhan syndrome is a very rare inborn disturbance of the purine metabolism almost exclusive of males 20 .
The study of the present case underlined some questions to be considered about PWS. First, although clinical scores are helpful for diagnosis and follow-up of PWS suspected cases, the features must be considered in accordance to age range as follows: 1) Birth to 2 years -hypotonia with poor suck; 2) Two to 6 years -hypotonia with history of poor suck, and global developmental delay; 3) Six to 12 years -history of hypotonia with poor suck, develo- Table 2 . Comparative gasometrical data including the first day of admission and the weight-loss phase (near one month before the hospital discharge)
pmental delay, excessive eating, and central obesity (if uncontrolled); and 4) 13 years through adulthood -cognitive impairment, excessive eating, central obesity (if uncontrolled), hypothalamic hypogonadism, and typical behavior problems 7 . Second, although SSRIs have been useful for management of the obsessive-compulsive and self-injurious behaviors in people with PWS, riskbenefits should be considered. Third, the occurrence of SIADH due to SSRIs must be enrolled among the etiologic factors of anasarca in patients with PWS, in special with a concomitant use of diuretics. Fourth, the respiratory disturbances related to morbid obesity are often severe and life threatening, but may be favorably influenced by a sustained program of weight loss. Bariatric surgery has been effective to treat morbidly obese patients with sleep apnea, and may result in appetite control with durable weight loss, lower mortality and better quality of life; however, the results in PWS may be poorer than in normal obesity 14 .
Lastly, the earliest as possible obesity prevention plays a major role in the quality of life of individuals with PWS. Furthermore, in spite of all the available clinical and surgical tools, the successful weight loss and maintenance is hardly accomplished.
